Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Measuring antibiotic levels and their relationship with the microbiome in chronic rhinosinusitis.

Siu J, Tingle MD, Douglas RG.

J Laryngol Otol. 2019 Oct 7:1-5. doi: 10.1017/S0022215119001932. [Epub ahead of print]

PMID:
31587675
2.

Systemic Immunologic Consequences of Chronic Periodontitis.

Gaudilliere DK, Culos A, Djebali K, Tsai AS, Ganio EA, Choi WM, Han X, Maghaireh A, Choisy B, Baca Q, Einhaus JF, Hedou JJ, Bertrand B, Ando K, Fallahzadeh R, Ghaemi MS, Okada R, Stanley N, Tanada A, Tingle M, Alpagot T, Helms JA, Angst MS, Aghaeepour N, Gaudilliere B.

J Dent Res. 2019 Aug;98(9):985-993. doi: 10.1177/0022034519857714. Epub 2019 Jun 21.

PMID:
31226001
3.

Subcutaneous nicotine delivery via needle-free jet injection: A porcine model.

Ruddy BP, Bullen C, Chu JTW, Jeong SH, Madadkhahsalmassi B, McKeage JW, Svirskis D, Tingle MD, Xu J, Taberner AJ.

J Control Release. 2019 Jul 28;306:83-88. doi: 10.1016/j.jconrel.2019.05.040. Epub 2019 May 29.

PMID:
31150748
4.

Multiomics modeling of the immunome, transcriptome, microbiome, proteome and metabolome adaptations during human pregnancy.

Ghaemi MS, DiGiulio DB, Contrepois K, Callahan B, Ngo TTM, Lee-McMullen B, Lehallier B, Robaczewska A, Mcilwain D, Rosenberg-Hasson Y, Wong RJ, Quaintance C, Culos A, Stanley N, Tanada A, Tsai A, Gaudilliere D, Ganio E, Han X, Ando K, McNeil L, Tingle M, Wise P, Maric I, Sirota M, Wyss-Coray T, Winn VD, Druzin ML, Gibbs R, Darmstadt GL, Lewis DB, Partovi Nia V, Agard B, Tibshirani R, Nolan G, Snyder MP, Relman DA, Quake SR, Shaw GM, Stevenson DK, Angst MS, Gaudilliere B, Aghaeepour N.

Bioinformatics. 2019 Jan 1;35(1):95-103. doi: 10.1093/bioinformatics/bty537.

5.

Ascending single dose pharmacokinetics of cytisine in healthy adult smokers.

Jeong SH, Sheridan J, Bullen C, Newcombe D, Walker N, Tingle M.

Xenobiotica. 2019 Nov;49(11):1332-1337. doi: 10.1080/00498254.2018.1557760. Epub 2019 Jun 19.

PMID:
30526213
6.

Use of Coronial Post-mortem Tissue for Research in New Zealand.

Bellissima BL, Garavan F, Skinner JR, Tingle MD.

J Law Med. 2017 Nov;25(1):205-209.

PMID:
29978632
7.

Corrigendum to "A systematic review of clozapine-induced myocarditis" [Int. J. Cardiol. 259(2018) 122-129].

Bellissima BL, Tingle MD, Cicović A, Alawami M, Kenedi C.

Int J Cardiol. 2018 Jul 15;263:187. doi: 10.1016/j.ijcard.2018.03.091. Epub 2018 Apr 11. No abstract available.

PMID:
29655954
8.

A systematic review of clozapine-induced myocarditis.

Bellissima BL, Tingle MD, Cicović A, Alawami M, Kenedi C.

Int J Cardiol. 2018 May 15;259:122-129. doi: 10.1016/j.ijcard.2017.12.102. Review. Erratum in: Int J Cardiol. 2018 Apr 11;:.

PMID:
29579587
9.

Plasma concentrations of cytisine, a commercially available plant-based alkaloid, in healthy adult smokers taking recommended doses for smoking cessation.

Jeong SH, Sheridan J, Newcombe D, Tingle M.

Xenobiotica. 2018 Dec;48(12):1245-1248. doi: 10.1080/00498254.2017.1409916. Epub 2017 Dec 12.

PMID:
29168931
10.

An immune clock of human pregnancy.

Aghaeepour N, Ganio EA, Mcilwain D, Tsai AS, Tingle M, Van Gassen S, Gaudilliere DK, Baca Q, McNeil L, Okada R, Ghaemi MS, Furman D, Wong RJ, Winn VD, Druzin ML, El-Sayed YY, Quaintance C, Gibbs R, Darmstadt GL, Shaw GM, Stevenson DK, Tibshirani R, Nolan GP, Lewis DB, Angst MS, Gaudilliere B.

Sci Immunol. 2017 Sep 1;2(15). pii: eaan2946. doi: 10.1126/sciimmunol.aan2946.

11.

Indirect regulation of CYP2C19 gene expression via DNA methylation.

Burns KE, Shepherd P, Finlay G, Tingle MD, Helsby NA.

Xenobiotica. 2018 Aug;48(8):781-792. doi: 10.1080/00498254.2017.1372648. Epub 2017 Sep 19.

PMID:
28840784
12.

Deep Immune Profiling of an Arginine-Enriched Nutritional Intervention in Patients Undergoing Surgery.

Aghaeepour N, Kin C, Ganio EA, Jensen KP, Gaudilliere DK, Tingle M, Tsai A, Lancero HL, Choisy B, McNeil LS, Okada R, Shelton AA, Nolan GP, Angst MS, Gaudilliere BL.

J Immunol. 2017 Aug 9. pii: ji1700421. doi: 10.4049/jimmunol.1700421. [Epub ahead of print]

13.

Human umbilical cord plasma proteins revitalize hippocampal function in aged mice.

Castellano JM, Mosher KI, Abbey RJ, McBride AA, James ML, Berdnik D, Shen JC, Zou B, Xie XS, Tingle M, Hinkson IV, Angst MS, Wyss-Coray T.

Nature. 2017 Apr 27;544(7651):488-492. doi: 10.1038/nature22067. Epub 2017 Apr 19.

14.

Pharmacokinetic Properties of Adenosine Amine Congener in Cochlear Perilymph after Systemic Administration.

Chang H, Telang RS, Sreebhavan S, Tingle M, Thorne PR, Vlajkovic SM.

Biomed Res Int. 2017;2017:8091462. doi: 10.1155/2017/8091462. Epub 2017 Jan 18.

15.

Varenicline improves motor and cognitive deficits and decreases depressive-like behaviour in late-stage YAC128 mice.

McGregor AL, D'Souza G, Kim D, Tingle MD.

Neuropharmacology. 2017 Apr;116:233-246. doi: 10.1016/j.neuropharm.2016.12.021. Epub 2016 Dec 23.

PMID:
28025093
16.

Mapping the Fetomaternal Peripheral Immune System at Term Pregnancy.

Fragiadakis GK, Baca QJ, Gherardini PF, Ganio EA, Gaudilliere DK, Tingle M, Lancero HL, McNeil LS, Spitzer MH, Wong RJ, Shaw GM, Darmstadt GL, Sylvester KG, Winn VD, Carvalho B, Lewis DB, Stevenson DK, Nolan GP, Aghaeepour N, Angst MS, Gaudilliere BL.

J Immunol. 2016 Dec 1;197(11):4482-4492. Epub 2016 Oct 28.

17.

Varenicline improves motor and cognitive symptoms in early Huntington's disease.

McGregor AL, Dysart J, Tingle MD, Russell BR, Kydd RR, Finucane G.

Neuropsychiatr Dis Treat. 2016 Sep 19;12:2381-2386. eCollection 2016.

18.

Antibody responses to influenza vaccine in pre- and post-lung transplant patients.

Miller RM, Rohde KA, Tingle MT, Moran JJ, Hayney MS.

Clin Transplant. 2016 May;30(5):606-12. doi: 10.1111/ctr.12726. Epub 2016 Mar 20.

PMID:
26928266
19.

Patient-specific Immune States before Surgery Are Strong Correlates of Surgical Recovery.

Fragiadakis GK, Gaudillière B, Ganio EA, Aghaeepour N, Tingle M, Nolan GP, Angst MS.

Anesthesiology. 2015 Dec;123(6):1241-55. doi: 10.1097/ALN.0000000000000887.

20.

Implementing Mass Cytometry at the Bedside to Study the Immunological Basis of Human Diseases: Distinctive Immune Features in Patients with a History of Term or Preterm Birth.

Gaudillière B, Ganio EA, Tingle M, Lancero HL, Fragiadakis GK, Baca QJ, Aghaeepour N, Wong RJ, Quaintance C, El-Sayed YY, Shaw GM, Lewis DB, Stevenson DK, Nolan GP, Angst MS.

Cytometry A. 2015 Sep;87(9):817-29. doi: 10.1002/cyto.a.22720. Epub 2015 Jul 17.

21.

Clinical recovery from surgery correlates with single-cell immune signatures.

Gaudillière B, Fragiadakis GK, Bruggner RV, Nicolau M, Finck R, Tingle M, Silva J, Ganio EA, Yeh CG, Maloney WJ, Huddleston JI, Goodman SB, Davis MM, Bendall SC, Fantl WJ, Angst MS, Nolan GP.

Sci Transl Med. 2014 Sep 24;6(255):255ra131. doi: 10.1126/scitranslmed.3009701.

22.

Adenosine amine congener as a cochlear rescue agent.

Vlajkovic SM, Chang H, Paek SY, Chi HH, Sreebhavan S, Telang RS, Tingle M, Housley GD, Thorne PR.

Biomed Res Int. 2014;2014:841489. doi: 10.1155/2014/841489. Epub 2014 Aug 26.

23.

Pharmacokinetics of cytisine, an α4 β2 nicotinic receptor partial agonist, in healthy smokers following a single dose.

Jeong SH, Newcombe D, Sheridan J, Tingle M.

Drug Test Anal. 2015 Jun;7(6):475-82. doi: 10.1002/dta.1707. Epub 2014 Sep 17.

PMID:
25231024
24.

Regulating new psychoactive drugs: innovation leading to compromise.

Schep LJ, Gee P, Tingle M, Galea S, Newcombe D.

BMJ. 2014 Aug 13;349:g5085. doi: 10.1136/bmj.g5085. No abstract available.

PMID:
25122194
25.

Synthesis and methemoglobinemia-inducing properties of benzocaine isosteres designed as humane rodenticides.

Conole D, Beck TM, Jay-Smith M, Tingle MD, Eason CT, Brimble MA, Rennison D.

Bioorg Med Chem. 2014 Apr 1;22(7):2220-35. doi: 10.1016/j.bmc.2014.02.013. Epub 2014 Feb 20.

PMID:
24602400
26.

Synthesis and methemoglobinemia-inducing properties of analogues of para-aminopropiophenone designed as humane rodenticides.

Rennison D, Conole D, Tingle MD, Yang J, Eason CT, Brimble MA.

Bioorg Med Chem Lett. 2013 Dec 15;23(24):6629-35. doi: 10.1016/j.bmcl.2013.10.046. Epub 2013 Oct 31.

PMID:
24210502
27.

Pharmacokinetics and in vivo chemosuppressive activity studies on cryptolepine hydrochloride and cryptolepine hydrochloride-loaded gelatine nanoformulation designed for parenteral administration for the treatment of malaria.

Kuntworbe N, Ofori M, Addo P, Tingle M, Al-Kassas R.

Acta Trop. 2013 Sep;127(3):165-73. doi: 10.1016/j.actatropica.2013.04.010. Epub 2013 Apr 30.

PMID:
23643517
28.

Aversive and reinforcing opioid effects: a pharmacogenomic twin study.

Angst MS, Lazzeroni LC, Phillips NG, Drover DR, Tingle M, Ray A, Swan GE, Clark JD.

Anesthesiology. 2012 Jul;117(1):22-37. doi: 10.1097/ALN.0b013e31825a2a4e.

29.

Pain sensitivity and opioid analgesia: a pharmacogenomic twin study.

Angst MS, Phillips NG, Drover DR, Tingle M, Ray A, Swan GE, Lazzeroni LC, Clark JD.

Pain. 2012 Jul;153(7):1397-409. doi: 10.1016/j.pain.2012.02.022. Epub 2012 Mar 22.

30.

Which CYP2B6 variants have functional consequences for cyclophosphamide bioactivation?

Helsby NA, Tingle MD.

Drug Metab Dispos. 2012 Mar;40(3):635-7. doi: 10.1124/dmd.111.043646. Epub 2011 Dec 8. No abstract available.

PMID:
22159699
31.

Choosing between live attenuated and trivalent inactivated influenza vaccines for healthy children.

Tingle MT, Hayney MS.

J Am Pharm Assoc (2003). 2011 Nov-Dec;51(6):776-7. doi: 10.1331/JAPhA.2011.11547. No abstract available.

PMID:
22068202
32.

The importance of correct assignment of CYP2B6 genetic variants with respect to cyclophosphamide metabolizer status.

Helsby N, Tingle M.

Am J Hematol. 2011 Apr;86(4):383-4; author reply 384. doi: 10.1002/ajh.21987. No abstract available.

33.

Glucuronidation of anticancer prodrug PR-104A: species differences, identification of human UDP-glucuronosyltransferases, and implications for therapy.

Gu Y, Tingle MD, Wilson WR.

J Pharmacol Exp Ther. 2011 Jun;337(3):692-702. doi: 10.1124/jpet.111.180703. Epub 2011 Mar 22.

PMID:
21427202
34.

The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation.

Helsby NA, Hui CY, Goldthorpe MA, Coller JK, Soh MC, Gow PJ, De Zoysa JZ, Tingle MD.

Br J Clin Pharmacol. 2010 Dec;70(6):844-53. doi: 10.1111/j.1365-2125.2010.03789.x.

35.

Comparative bioactivation of the novel anti-tuberculosis agent PA-824 in Mycobacteria and a subcellular fraction of human liver.

Dogra M, Palmer BD, Bashiri G, Tingle MD, Shinde SS, Anderson RF, O'Toole R, Baker EN, Denny WA, Helsby NA.

Br J Pharmacol. 2011 Jan;162(1):226-36. doi: 10.1111/j.1476-5381.2010.01040.x.

36.

Opioid pharmacogenomics using a twin study paradigm: methods and procedures for determining familial aggregation and heritability.

Angst MS, Phillips NG, Drover DR, Tingle M, Galinkin JL, Christians U, Swan GE, Lazzeroni LC, Clark JD.

Twin Res Hum Genet. 2010 Oct;13(5):412-25. doi: 10.1375/twin.13.5.412.

PMID:
20874462
37.
38.

The analgesic and antihyperalgesic effects of transcranial electrostimulation with combined direct and alternating current in healthy volunteers.

Nekhendzy V, Lemmens HJ, Tingle M, Nekhendzy M, Angst MS.

Anesth Analg. 2010 Nov;111(5):1301-7. doi: 10.1213/ANE.0b013e3181e3697e. Epub 2010 Jun 8.

PMID:
20530614
39.

'Party pill' drugs--BZP and TFMPP.

Antia U, Tingle MD, Russell BR.

N Z Med J. 2009 Dec 11;122(1307):55-68. Review. Erratum in: N Z Med J. 2010 Jun 11;123(1316):139. Tingle, Malcolm D [added]; Russell, Bruce R [added].

PMID:
20148045
40.

In vivo interactions between BZP and TFMPP (party pill drugs).

Antia U, Tingle MD, Russell BR.

N Z Med J. 2009 Sep 25;122(1303):29-38.

PMID:
19851418
41.

Metabolic interactions with piperazine-based 'party pill' drugs.

Antia U, Tingle MD, Russell BR.

J Pharm Pharmacol. 2009 Jul;61(7):877-82. doi: 10.1211/jpp/61.07.0006.

PMID:
19589229
42.

In vivo metabolism of norbormide in rats and mice.

Ravindran S, Hopkins B, Bova S, Tingle M.

Environ Toxicol Pharmacol. 2009 Jul;28(1):147-51. doi: 10.1016/j.etap.2009.03.013. Epub 2009 Apr 8.

PMID:
21783995
43.

Party pills and drug-drug interactions.

Murphy M, Antia U, Chang HY, Han JY, Ibrahim U, Tingle M, Russell B.

N Z Med J. 2009 Apr 24;122(1293):3564.

PMID:
19448787
44.

Pharmacokinetics of 'party pill' drug N-benzylpiperazine (BZP) in healthy human participants.

Antia U, Lee HS, Kydd RR, Tingle MD, Russell BR.

Forensic Sci Int. 2009 Apr 15;186(1-3):63-7. doi: 10.1016/j.forsciint.2009.01.015. Epub 2009 Mar 3.

PMID:
19261399
45.

Determining heat and mechanical pain threshold in inflamed skin of human subjects.

Angst MS, Tingle M, Phillips NG, Carvalho B.

J Vis Exp. 2009 Jan 14;(23). pii: 1092. doi: 10.3791/1092.

46.

Human in-vivo bioassay for the tissue-specific measurement of nociceptive and inflammatory mediators.

Angst MS, Tingle M, Schmelz M, Carvalho B, Yeomans DC.

J Vis Exp. 2008 Dec 1;(22). pii: 1074. doi: 10.3791/1074.

47.

No evidence for the development of acute tolerance to analgesic, respiratory depressant and sedative opioid effects in humans.

Angst MS, Chu LF, Tingle MS, Shafer SL, Clark JD, Drover DR.

Pain. 2009 Mar;142(1-2):17-26. doi: 10.1016/j.pain.2008.11.001. Epub 2009 Jan 9.

PMID:
19135798
48.

In vitro metabolism of norbormide in rat, mouse and guinea pig liver preparations.

Ravindran S, Hopkins B, Bova S, Rennison D, Brimble M, Tingle M.

Environ Toxicol Pharmacol. 2009 Jan;27(1):144-8. doi: 10.1016/j.etap.2008.09.007. Epub 2008 Oct 19.

PMID:
21783932
49.

Comparative protein binding, stability and degradation of satraplatin, JM118 and cisplatin in human plasma in vitro.

Bell DN, Liu JJ, Tingle MD, Rattel B, Meyer TU, McKeage MJ.

Clin Exp Pharmacol Physiol. 2008 Dec;35(12):1440-6. doi: 10.1111/j.1440-1681.2008.05017.x. Epub 2008 Jul 29.

PMID:
18671714
50.

Cytokine profile in human skin in response to experimental inflammation, noxious stimulation, and administration of a COX-inhibitor: a microdialysis study.

Angst MS, Clark JD, Carvalho B, Tingle M, Schmelz M, Yeomans DC.

Pain. 2008 Sep 30;139(1):15-27. doi: 10.1016/j.pain.2008.02.028. Epub 2008 Apr 8.

PMID:
18396374

Supplemental Content

Loading ...
Support Center